Lonza
Maya Gonen-Wadmany is an accomplished professional in the field of biomedical engineering with extensive experience in research and development. With a Ph.D. and M.Sc. from Technion - Israel Institute of Technology, Maya has held significant roles at prominent organizations, including Lonza as Associate Director, R&D, and previously as Process Innovation and Science Manager at Pluristem Therapeutics. Expertise includes the development and characterization of novel cell therapy products, tissue culture in both 2D and 3D formats, and bioreactor project management. Maya's early research contributions at Technion focused on tissue engineering and mechanical stimulation of cardiac tissue, showcasing a strong foundation in innovative biomaterials and bioreactor design.
This person is not in any teams
This person is not in any offices
Lonza
66 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.